TABLE 1.
MICs of macrolides and related agents for 88 erythromycin-resistant GBS isolates according to known mechanisms of resistance
Group (n) and antimicrobial agent | MICa (μg/ml)
|
||
---|---|---|---|
50% | 90% | Range | |
All isolates (88)b | |||
Erythromycin | 4 | >128 | 0.5->128 |
Azithromycin | 16 | >128 | 1->128 |
Clindamycin | 64 | >128 | 0.064->128 |
Telithromycin | 0.125 | 0.5 | 0.032-2 |
ermB (50) | |||
Erythromycin | 128 | >128 | 0.5->128 |
Azithromycin | >128 | >128 | 2->128 |
Clindamycin | 64 | >128 | 0.25->128 |
Telithromycin | 0.125 | 1 | 0.064-2 |
ermA (28) | |||
Erythromycin | 2 | 8 | 0.5-16 |
Azithromycin | 8 | 32 | 1-64 |
Clindamycin | 0.5 | 128 | 0.064->128 |
Telithromycin | 0.064 | 0.064 | 0.032-0.125 |
mefA (8) | |||
Erythromycin | 2 | 4 | 2-4 |
Azithromycin | 2 | 4 | 2-4 |
Clindamycin | 0.064 | 0.125 | 0.064-0.125 |
Telithromycin | 0.25 | 0.25 | 0.125-0.5 |
50 and 90%, MIC50 and MIC90, respectively.
Two isolates were negative for ermA, ermB, and mefA genes.